Live Breaking News & Updates on Tianshu Liu

Stay updated with breaking news from Tianshu liu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting

/PRNewswire/ Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in. ....

Mccormick Place , United States , Los Angeles , Jifang Gong , Tianshu Liu , Clinical Development Centers , Transcenta Holding , American Society Of Clinical Oncology , University Cancer Hospital , Product Development Center , Translational Research Center , Group Headquarters , Prnewswire Transcenta Holding Limited , Fudan University , Research Institute , Transcenta Immune Tolerance Breaking Technology , Business Development , Holding Limited , American Society , Clinical Oncology , Phasei Study , High Affinity Humanized , First Line Treatment , Chinese Solid Tumor , Professor Jifang Gong , Peking University Cancer Hospital ,

Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting

/PRNewswire/ Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in. ....

Mccormick Place , United States , Los Angeles , Jifang Gong , Tianshu Liu , Clinical Development Centers , Transcenta Holding , American Society Of Clinical Oncology , University Cancer Hospital , Product Development Center , Translational Research Center , Group Headquarters , Prnewswire Transcenta Holding Limited , Fudan University , Research Institute , Transcenta Immune Tolerance Breaking Technology , Business Development , Holding Limited , American Society , Clinical Oncology , Phasei Study , High Affinity Humanized , First Line Treatment , Chinese Solid Tumor , Professor Jifang Gong , Peking University Cancer Hospital ,